Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-21

Clinical Trial Update: An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia [Phase 3]

View source ↗

Summary

This document reports the completion and public posting of Phase 3 results evaluating the efficacy and safety of extended-release paliperidone in adolescent par…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVEGA (PALIPERIDONE)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2013-06-21